These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11310524)

  • 21. Serotonin syndrome in maintenance haemodialysis patients following sertraline treatment for depression.
    Chander WP; Singh N; Mukhiya GK
    J Indian Med Assoc; 2011 Jan; 109(1):36-7. PubMed ID: 21888157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors.
    Swartz JR; Miller BL; Lesser IM; Darby AL
    J Clin Psychiatry; 1997 May; 58(5):212-6. PubMed ID: 9184615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder.
    Rothbaum BO; Killeen TK; Davidson JR; Brady KT; Connor KM; Heekin MH
    J Clin Psychiatry; 2008 Apr; 69(4):520-5. PubMed ID: 18278987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relapse of depressive symptoms after discontinuing sertraline.
    Baldessarini RJ; Viguera AC
    JAMA; 1999 Jul; 282(4):323-4. PubMed ID: 10432022
    [No Abstract]   [Full Text] [Related]  

  • 25. Sertraline treatment of interferon-alfa-induced depressive disorder.
    Schramm TM; Lawford BR; Macdonald GA; Cooksley WG
    Med J Aust; 2000 Oct; 173(7):359-61. PubMed ID: 11062791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders.
    MacQueen G; Born L; Steiner M
    CNS Drug Rev; 2001; 7(1):1-24. PubMed ID: 11420570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of intermittent explosive disorder with sertraline in 3 patients.
    Feder R
    J Clin Psychiatry; 1999 Mar; 60(3):195-6. PubMed ID: 10192598
    [No Abstract]   [Full Text] [Related]  

  • 28. Rapid response of emotional incontinence to selective serotonin reuptake inhibitors.
    Nahas Z; Arlinghaus KA; Kotrla KJ; Clearman RR; George MS
    J Neuropsychiatry Clin Neurosci; 1998; 10(4):453-5. PubMed ID: 9813792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rifampin-induced selective serotonin reuptake inhibitor withdrawal syndrome in a patient treated with sertraline.
    Markowitz JS; DeVane CL
    J Clin Psychopharmacol; 2000 Feb; 20(1):109-10. PubMed ID: 10653222
    [No Abstract]   [Full Text] [Related]  

  • 30. Serotonin syndrome with ziprasidone and sertraline.
    Palekar N; Eisman J
    J Neuropsychiatry Clin Neurosci; 2013; 25(2):E1. PubMed ID: 23686039
    [No Abstract]   [Full Text] [Related]  

  • 31. Potential indications for the selective serotonin reuptake inhibitors.
    Boyer WF
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 5():5-12. PubMed ID: 1431022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregabalin versus sertraline in generalized anxiety disorder. An open label study.
    Cvjetkovic-Bosnjak M; Soldatovic-Stajic B; Babovic SS; Boskovic K; Jovicevic M
    Eur Rev Med Pharmacol Sci; 2015; 19(11):2120-4. PubMed ID: 26125277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sertraline-associated hair loss.
    Ghanizadeh A
    J Drugs Dermatol; 2008 Jul; 7(7):693-4. PubMed ID: 18664165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sertraline Reduces Risk of Depression in Adults After Traumatic Brain Injury.
    Slawson D
    Am Fam Physician; 2017 Feb; 95(3):194. PubMed ID: 28145678
    [No Abstract]   [Full Text] [Related]  

  • 35. Sertraline in the treatment of hiccups.
    Vaidya V
    Psychosomatics; 2000; 41(4):353-5. PubMed ID: 10906358
    [No Abstract]   [Full Text] [Related]  

  • 36. A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil.
    Finkel SI; Mintzer JE; Dysken M; Krishnan KR; Burt T; McRae T
    Int J Geriatr Psychiatry; 2004 Jan; 19(1):9-18. PubMed ID: 14716694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reducing impulsivity in repeat violent offenders: an open label trial of a selective serotonin reuptake inhibitor.
    Butler T; Schofield PW; Greenberg D; Allnutt SH; Indig D; Carr V; D'Este C; Mitchell PB; Knight L; Ellis A
    Aust N Z J Psychiatry; 2010 Dec; 44(12):1137-43. PubMed ID: 21070110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial.
    Salaminios G; Duffy L; Ades A; Araya R; Button KS; Churchill R; Croudace T; Derrick C; Dixon P; Dowrick C; Gilbody S; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Lanham P; Malpass A; Peters TJ; Riozzie D; Robinson J; Sharp D; Thomas L; Welton NJ; Wiles N; Lewis G
    Trials; 2017 Oct; 18(1):496. PubMed ID: 29065916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sertraline in underweight binge eating/purging-type eating disorders: five case reports.
    Frank GK; Kaye WH; Marcus MD
    Int J Eat Disord; 2001 May; 29(4):495-8. PubMed ID: 11285589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delirium in HIV-associated dementia.
    Kapetanovic S; Simpson GM
    J Am Acad Child Adolesc Psychiatry; 2006 Jul; 45(7):767-8; reply 768-9. PubMed ID: 16832311
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.